United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...

With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to ...

Makers of drugs and medical devices say the tariffs on goods from Canada, Mexico and China could have an outsized impact on ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

All three were hooked up to machines that provided a readout of their vital signs, and all three were prepared to have a ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

United Therapeutics' clinical trial represents a significant advancement in addressing the organ shortage crisis and improving the survival and quality of life for ESRD patients. With a P/E ratio ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...